|
⚲
|
| Keyboard |
| Emerson Erik
✚
|
|
|---|---|
| CIK # | 0001710496 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001710496] | |
| 4 | [0001710496] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Apimeds Pharmaceuticals US Inc | |
| Emerson Erik | |
| Odyssey Health Inc | |
| Adhera Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-10-15 | Grant | 215,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Stock option (right to buy) · derivative
|
2025-05-16 | Grant | 347,279 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Common Stock, par value $0.01 per share
|
2025-05-16 | Grant | 750,000 | $0.00 | |
|
Odyssey Health Inc ODYY
Stock Option (Right to Buy) · derivative
|
2024-01-16 | Grant | 37,500 | $0.09 | 3,375 |
|
Odyssey Health Inc ODYY
Stock Option (Right to Buy) · derivative
|
2023-12-29 | Grant | 200,000 | $0.10 | 20,000 |
|
Odyssey Health Inc ODYY
Stock Option - Right to buy · derivative
|
2022-11-01 | Grant | 125,000 | $0.25 | 31,250 |
|
Odyssey Health Inc ODYY
Stock Option - Right to buy · derivative
|
2022-11-01 | Grant | 475,000 | $0.25 | 118,750 |
|
Adhera Therapeutics Inc MRNA
Options to purchase common stock · derivative
|
2018-07-10 | Grant | 1,125,000 | $0.00 |